positive association of dementia with mortality significant even after all adjustments, HR=2.65 (95% CI: 1.02-6.92), p: 0.045. After subgroup analysis, there was no significant association between mortality and dementia according to frailty status. Our study results suggest that dementia is associated with a higher risk for mortality in Veterans at a Memory Disorders clinic. Frailty did not modify the effect.
, 1. Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States, 2. Paul F. Glenn Center for Biology of Aging Research at Harvard Medical School, Boston, Massachusetts, United States
While late-onset dietary (e.g. calorie restriction) or pharmacological (e.g. rapamycin) interventions can extend longevity in rodents, whether or not they can be used to reverse or forestall onset of aging-related symptoms (i.e. frailty) remains untested. Here, we employed methionine restriction (MR), a dietary intervention associated with weight loss and longevity extension, or a fumagillin derivative, ZGN-1062, as a pharmacological agent associated with weight loss across multiple species. 21mo Male and female C57BL/6 mice were randomized to one of three groups: control, 0.1% MetR, or ZGN-1062 (1.5mg/ kg). There was no difference in frailty index (FI) amongst groups at baseline (21 mo age). MetR and ZGN-1062 treatments resulted in modest weight loss independent of sex. After 6 months, FI increased consistent with reduced healthspan in control males (0.23+/-0.01 to 0.34+/-0.01 A.U, p<0.0001) and females at this age (0.19+/-0.03 to 0.24+/-0.01, p<0.0001). Male MetR and ZGN-1062 mice had significantly lower FI scores after 6 mo of treatment (MetR: 0.28+/-0.04, p<0.0001; ZGN-1062: 0.29+/-0.05, p=0.0002). While female mice were not significantly different from controls, they were, overall, less frail than males at 26 months, suggesting sexual dimorphism in the timing frailty onset in mice. Although the end points of this study have not been reached (survival studies are ongoing), the data obtained to date suggest that late-life treatments can improve healthspan markers, at least in male mice. Such treatments include a pharmacological intervention associated with weight loss, which may be a more practical therapeutic strategy towards mitigation of age-related healthspan decline than dietary restrictionbased interventions. Task-specific power training (InVEST) targets leg power and mobility skills that are beneficial for treating slow gait speed for older adults. This study investigated the efficacy of a short-term InVEST training on leg power, mobility performance, and gait characteristics and further examine whether the addition of cognitive training would augment the impact on the outcomes. Mobility limited community-dwelling older Veterans age ≥65 years were recruited. Participants were randomly assigned to either InVEST training (n=10) or InVEST+cognitive training (n=11). Training occurred 3 times per week for 6 weeks. Sessions were either 70 minutes (InVest+cognitive training) or 40 minutes (InVEST) in duration. Leg power, mobility performance (Short Physical Performance Battery), and gait characteristics (gait speed, stance time, step width, swing time, step length and their variabilities under single-task, simple and complex dual-task walking conditions) were evaluated. Twenty-one men with mean age 76±7 years completed the study and 86% were of white race. Among all participants, clinically relevant and statistically significant improvements in leg power, mobility performance, and gait characteristics (gait speed, step length, stance time under all three gait conditions) were observed. There were no statistically significant or clinically relevant group differences among any of the outcomes based on cognitive training status. Short-term InVEST training led to clinically meaningful improvements in leg power, mobility performance, and gait characteristics. These findings add to the body of evidence supporting the benefits of InVEST training on mobility and do not support the contention that mixed modes of training (cognitive and physical) may augment mobility outcomes. Carolina, Columbia, South Carolina, United States, 2. Drexel University, Philadelphia, Pennsylvania, United States Research has examined the relationship between neighborhood environments and cognitive decline, yet few have investigated the role of neighborhood characteristics specifically on dementia. This ecologic study examined the geographic distribution of dementia incidence and investigated ecologic associations between census-tract neighborhood characteristics and diagnosed dementia case incidence from 2010-2014 in the South Carolina (SC) Alzheimer's Disease Registry. Analyses took place on the census-tract level (n=1089) with population ≥1. Neighborhood measures came from the Decennial Census, American Community Survey, Rural Commuting Area Code, and County Health Rankings. To estimate the ecologic association between neighborhood characteristics and dementia incidence, we conducted a zeroinflated, negative binomial mixed-effects model. The overall age-sex standardized dementia incidence rate was 2,885.4 per 100,000 people per census tract from 2010 -2014 in SC Innovation in Aging, 2019 
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